Her new doctor immediately took action, performing a series of tests and soon discovering what others had missed: Avi had ...

The FDA has loosened safety restrictions for six CAR T-cell immunotherapies, used in treating a number of blood cancers.

University of Kentucky Markey Cancer Center researcher Weisi Yan, M.D., Ph.D., recently shared his work on radiation therapy ...

The Food and Drug Administration has announced new guidelines that will make CAR T-cell therapy more accessible to cancer ...

Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...

Denise Schipani is a New York–based editor and writer with a special interest in health and healthcare. Her work has appeared in a wide range of consumer and custom magazines and websites. She's at ...

Mayo Clinic researchers say they have identified why some cancer patients relapse after receiving CAR-T cell therapy. The study, published in Molecular Cancer, reveals that the engineered immune cells ...

Since the February update, an additional 5 patients have been dosed, resulting in 2 Complete Responses (CR) and 3 Partial Responses (PR) 75% Overall Response rate (ORR): 6 total CR and ...

Since the February update, an additional 5 patients have been dosed, resulting in 2 Complete Responses (CR) and 3 Partial ...

Imugene continues to actively enrol patients into the Phase 1b azer-cel trial at ten US sites with up to six sites in ...

A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...

Exercise seems to help prevent cancer and reduce the growth of tumours, and that protective effect may be due to the way ...